These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 28288486
1. Differential Disease Progression in Atrophic Age-Related Macular Degeneration and Late-Onset Stargardt Disease. Lindner M, Lambertus S, Mauschitz MM, Bax NM, Kersten E, Lüning A, Nadal J, Schmitz-Valckenberg S, Schmid M, Holz FG, Hoyng CB, Fleckenstein M, Foveal sparing Atrophy Study Team (FAST). Invest Ophthalmol Vis Sci; 2017 Feb 01; 58(2):1001-1007. PubMed ID: 28288486 [Abstract] [Full Text] [Related]
3. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7. Schönbach EM, Wolfson Y, Strauss RW, Ibrahim MA, Kong X, Muñoz B, Birch DG, Cideciyan AV, Hahn GA, Nittala M, Sunness JS, Sadda SR, West SK, Scholl HPN, ProgStar Study Group. JAMA Ophthalmol; 2017 Jul 01; 135(7):696-703. PubMed ID: 28542693 [Abstract] [Full Text] [Related]
4. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease. Melillo P, Testa F, Rossi S, Di Iorio V, Orrico A, Auricchio A, Simonelli F. Invest Ophthalmol Vis Sci; 2016 Jul 01; 57(9):OCT247-52. PubMed ID: 27409479 [Abstract] [Full Text] [Related]
5. Choroidal Flow Signal in Late-Onset Stargardt Disease and Age-Related Macular Degeneration: An OCT-Angiography Study. Müller PL, Pfau M, Möller PT, Nadal J, Schmid M, Lindner M, de Sisternes L, Stöhr H, Weber BHF, Neuhaus C, Herrmann P, Schmitz-Valckenberg S, Holz FG, Fleckenstein M. Invest Ophthalmol Vis Sci; 2018 Mar 20; 59(4):AMD122-AMD131. PubMed ID: 30140905 [Abstract] [Full Text] [Related]
10. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease. Verdina T, Greenstein VC, Sodi A, Tsang SH, Burke TR, Passerini I, Allikmets R, Virgili G, Cavallini GM, Rizzo S. Graefes Arch Clin Exp Ophthalmol; 2017 Jul 20; 255(7):1307-1317. PubMed ID: 28365912 [Abstract] [Full Text] [Related]
13. The absence of fundus abnormalities in Stargardt disease. Bax NM, Lambertus S, Cremers FPM, Klevering BJ, Hoyng CB. Graefes Arch Clin Exp Ophthalmol; 2019 Jun 20; 257(6):1147-1157. PubMed ID: 30903310 [Abstract] [Full Text] [Related]
14. Vascular abnormalities in patients with Stargardt disease assessed with optical coherence tomography angiography. Battaglia Parodi M, Cicinelli MV, Rabiolo A, Pierro L, Bolognesi G, Bandello F. Br J Ophthalmol; 2017 Jun 20; 101(6):780-785. PubMed ID: 27628426 [Abstract] [Full Text] [Related]
15. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5. Strauss RW, Muñoz B, Ho A, Jha A, Michaelides M, Mohand-Said S, Cideciyan AV, Birch D, Hariri AH, Nittala MG, Sadda S, Scholl HPN, ProgStar Study Group. JAMA Ophthalmol; 2017 Jul 01; 135(7):687-695. PubMed ID: 28542697 [Abstract] [Full Text] [Related]
16. The dark atrophy with indocyanine green angiography in Stargardt disease. Giani A, Pellegrini M, Carini E, Peroglio Deiro A, Bottoni F, Staurenghi G. Invest Ophthalmol Vis Sci; 2012 Jun 26; 53(7):3999-4004. PubMed ID: 22589445 [Abstract] [Full Text] [Related]